1. Home
  2. XELB vs VRAX Comparison

XELB vs VRAX Comparison

Compare XELB & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • VRAX
  • Stock Information
  • Founded
  • XELB 2011
  • VRAX 2013
  • Country
  • XELB United States
  • VRAX United Kingdom
  • Employees
  • XELB N/A
  • VRAX N/A
  • Industry
  • XELB Multi-Sector Companies
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • XELB Miscellaneous
  • VRAX Health Care
  • Exchange
  • XELB Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • XELB 19.0M
  • VRAX 17.2M
  • IPO Year
  • XELB N/A
  • VRAX 2022
  • Fundamental
  • Price
  • XELB $0.76
  • VRAX $1.97
  • Analyst Decision
  • XELB
  • VRAX
  • Analyst Count
  • XELB 0
  • VRAX 0
  • Target Price
  • XELB N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • XELB 18.1K
  • VRAX 4.9M
  • Earning Date
  • XELB 11-26-2024
  • VRAX 11-26-2024
  • Dividend Yield
  • XELB N/A
  • VRAX N/A
  • EPS Growth
  • XELB N/A
  • VRAX N/A
  • EPS
  • XELB N/A
  • VRAX N/A
  • Revenue
  • XELB $10,062,000.00
  • VRAX $156,419.00
  • Revenue This Year
  • XELB N/A
  • VRAX $5,169.18
  • Revenue Next Year
  • XELB $82.99
  • VRAX $66.97
  • P/E Ratio
  • XELB N/A
  • VRAX N/A
  • Revenue Growth
  • XELB N/A
  • VRAX 1727.11
  • 52 Week Low
  • XELB $0.58
  • VRAX $0.60
  • 52 Week High
  • XELB $1.70
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • XELB 44.82
  • VRAX 46.98
  • Support Level
  • XELB $0.75
  • VRAX $1.92
  • Resistance Level
  • XELB $0.80
  • VRAX $2.50
  • Average True Range (ATR)
  • XELB 0.02
  • VRAX 0.22
  • MACD
  • XELB -0.01
  • VRAX 0.01
  • Stochastic Oscillator
  • XELB 0.00
  • VRAX 26.97

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: